ArticlePharmaceutical research2017

Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.

Tapan K Dash et al.PubMed ↗Publisher ↗

No numbers read from the abstract.